FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/02/2026
Back to search
Official data from USPTO
MACRILEN (MACIMORELIN) GRANULES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
07/02/2026
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
12/03/2024
Registration date
11/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/25/2025
Last transaction
07/02/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
16
Owner location
DE
Examiner
OPUTA, CHIOMA N
Law office
L30
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the wording "MACRILEN", with a triangular design, composed of three curved triangle like shapes, to the left of the wording. Below "MACRILEN" is the wording "(MACIMORELIN) GRANULES".
Holders and representatives
Holders
AEterna Zentaris GmbH
Representatives
Jacqueline Brousseau Greenberg Traurig, LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic preparations for medical usediagnostic preparations for identifying and detecting growth hormone deficiency
Class 42
Scientific and technological servicesresearch and design in the field of medicine and diagnostics
Class 44
Medical and veterinary servicesin particular for the diagnosis of growth hormone deficiency.
Publications
History of USPTO decisions and trademark events.
25 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/11/2026
FIMP
FINAL DISPOSITION PROCESSED
06/11/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
06/11/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/25/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
05/25/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/25/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/25/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/07/2025
PUBO
PUBLISHED FOR OPPOSITION
10/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/21/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/21/2025
RFNT
REFUSAL PROCESSED BY IB
08/15/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/25/2025
RFRR
REFUSAL PROCESSED BY MPU
07/25/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/03/2025
CNRT
NON-FINAL ACTION WRITTEN
06/02/2025
DOCK
ASSIGNED TO EXAMINER
05/22/2025
MAFR
APPLICATION FILING RECEIPT MAILED
12/31/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/31/2024
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
12/26/2024
Continuous trademark protection
Get notified about every new filing that threatens MACRILEN (MACIMORELIN) GRANULES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.